Administrative Core
行政核心
基本信息
- 批准号:10472630
- 负责人:
- 金额:$ 62.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-18 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvisory CommitteesAfrican American populationAlabamaBehavior TherapyBiometryBlood GlucoseBlood PressureCardiovascular systemCenter for Translational Science ActivitiesClinicClinicalClinical ResearchClinical SciencesClinical TrialsCommunicationCommunitiesCommunity OutreachComplementDataDevelopmentDiseaseDoctor of PhilosophyEconomically Deprived PopulationEffectivenessEmployeeEnsureEvaluationExtramural ActivitiesFundingGoalsGrantHealthHealth SciencesInfrastructureInstitutesInstitutionInvestmentsLeadLeadershipLouisianaMarketingMeasuresMedical centerMemory impairmentMissionMississippiMonitorNCI Scholars ProgramNational Institute of General Medical SciencesObesityOperations ResearchOutcomePerformancePeriodicityPhasePilot ProjectsPoliciesPopulation ResearchPopulation StudyProceduresProcessPublicationsRecommendationRecording of previous eventsResearchResearch ActivityResearch DesignResearch PersonnelResearch Project GrantsResearch SupportResource AllocationResourcesRural PopulationSchoolsScientistServicesStrategic PlanningStructureSuggestionTimeTranslational ResearchUniversitiesVascular DementiaWorkauthoritybaseblood glucose regulationcardiometabolismclinical centercollegecommunity engaged researchcommunity engagementepidemiology studyexperiencefaculty researchflexibilityhealth disparityimplementation scienceimprovedinterestmeetingsmultidisciplinaryneurodegenerative dementiaorganizational structurepopulation healthprogramsrural areascientific organizationsquare footsuccesstelehealthtranslational research programtrendworking group
项目摘要
PROJECT SUMMARY- ADMINISTRATIVE CORE.
The Mississippi Center for Clinical and Translational Research (MCCTR) was established in 2016 as a
collaborative venture among three institutional partners: Tougaloo College, the University of Southern
Mississippi, and the University of Mississippi Medical Center, The MCCTR has subsequently formed an
integrated research resource network, creating the infrastructure to address the substantial health burden and
health disparities that exist in Mississippi.
The organizational structure and leadership have clear lines of authority and responsibility and ensure close
monitoring of MCCTR progress and milestones. The leadership of the MCCTR, Joey Granger, PhD, who serves
as PI and Director, and Michael Hall, MD, MS, who serves as Director of Clinical and Population Research, have
worked closely with its Internal Advisory Committee (IAC) and External Advisory Committee (EAC) to leverage
existing research support and authority, optimize communication, and build on existing strengths. The constant
interchange of ideas and suggestions between the MCCTR leadership, EAC and IAC and the Tracking and
Evaluation Core during Years 1-4 of has led to significant improvements in MCCTR operations.
Moving forward, the MCCTR will increase focus on implementation science and clinical and behavioral
interventions to address the disparities associated with obesity- and cardiometabolic-related disorders in
Mississippi, where these health indicators are among the worst in the nation. Specifically, MCCTR will focus on
these Mississippi populations: African Americans, people living in rural areas, and those who are economically
disadvantaged.
To achieve this goal, MCCTR will also greatly expand its reach in the next funding cycle by adding strengths,
diversity and resources for clinical and translational (C/T) research by establishing new partnerships with the
University of Mississippi-Oxford campus and Mississippi State University—the two largest universities in the
state. MCCTR's impact on C/T research will also be greatly enhanced by inclusion of four CTSA/CTR Consortium
partners: the Louisiana Clinical and Translational Science Center (LACaTS), the Mayo Clinic Center for Clinical
and Translational Science (CCaTS), and our new partners: the University of Alabama-Birmingham Center for
Clinical and Translational Science (UAB-CCTS) and Northwestern University Clinical and Translational Sciences
Institute (NUCATS). MCCTR's in-state institutional partners and its consortium partners will be fully integrated
into the MCCTR through participation in its cores and working groups, through funding provided to Mississippi-
based investigators by its Pilot Projects Program and Professional Development Core, support from its
Community Engagement and Outreach Core, Research Services Core, and Biostatistics, Epidemiology, and
Research Design Core, and by representation on the MCCTR Steering Committee and Advisory Committees.
项目摘要 - 行政核心。
密西西比临床和转化研究中心 (MCCTR) 成立于 2016 年,作为
三个机构合作伙伴之间的合作项目:图加卢学院、南方大学
密西西比州和密西西比大学医学中心 MCCTR 随后成立了
综合研究资源网络,创建基础设施来解决巨大的健康负担和
密西西比州存在的健康差距。
组织架构和领导班子权责清晰,保证紧密联系
MCCTR 的领导者是 Joey Granger 博士,他负责监督 MCCTR 的进展和里程碑。
作为 PI 和主任,以及担任临床和人口研究主任的 Michael Hall(医学博士、理学硕士)
与其内部咨询委员会 (IAC) 和外部咨询委员会 (EAC) 密切合作,利用
现有的研究支持和权威,优化沟通,并利用现有的优势。
MCCTR 领导层、EAC 和 IAC 以及跟踪和跟踪小组之间交换意见和建议
第 1-4 年的核心评估使 MCCTR 运营取得了重大改进。
展望未来,MCCTR 将更加关注实施科学以及临床和行为
采取干预措施来解决与肥胖和心脏代谢相关疾病相关的差异
具体来说,密西西比州的这些健康指标是全国最差的,MCCTR 将重点关注该州。
这些密西西比州人口:非裔美国人、生活在农村地区的人和经济困难的人
处于不利地位。
为了实现这一目标,MCCTR 还将通过增加优势,在下一个融资周期中大大扩大其影响范围,
通过与以下机构建立新的合作伙伴关系,为临床和转化(C/T)研究提供多样性和资源
密西西比大学牛津校区和密西西比州立大学——美国最大的两所大学
四个 CTSA/CTR 联盟的加入也将大大增强 MCCTR 对 C/T 研究的影响。
合作伙伴:路易斯安那州临床和转化科学中心 (LACaTS)、梅奥诊所临床中心
和转化科学(CCaTS),以及我们的新合作伙伴:阿拉巴马大学伯明翰中心
临床与转化科学 (UAB-CCTS) 和西北大学临床与转化科学
研究所 (NUCATS) 的州内机构合作伙伴及其财团合作伙伴将完全整合。
通过参与其核心和工作组,通过向密西西比州提供资金,进入 MCCTR
其试点项目计划和专业发展核心的基础研究人员,其支持
社区参与和外展核心、研究服务核心以及生物统计学、流行病学和
研究设计核心,以及 MCCTR 指导委员会和咨询委员会的代表。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joey P. Granger其他文献
Intrauterine endotoxin infusion in rat pregnancy induces preterm delivery and increases placental prostaglandin F2alpha metabolite levels.
大鼠妊娠宫内输注内毒素可诱导早产并增加胎盘前列腺素 F2α 代谢水平。
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:9.8
- 作者:
William A. Bennett;D. Terrone;B. K. Rinehart;Sallah Kassab;James N. Martin;Joey P. Granger - 通讯作者:
Joey P. Granger
Control of Renal Hemodynamics During Intrarenal and Systemic Blockade of Nitric Oxide Synthesis in Conscious Dogs
清醒犬肾内和全身阻断一氧化氮合成期间肾脏血流动力学的控制
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:3
- 作者:
Joey P. Granger;Antonio M. Alberola;F. Salazar;Tetsuya Nakamura - 通讯作者:
Tetsuya Nakamura
Effects of Renal Perfusion Pressure on Renal Interstitial Hydrostatic Pressure and Na+ Excretion: Role of Endothelium-Derived Nitric Oxide
肾灌注压对肾间质静水压和钠排泄的影响:内皮源性一氧化氮的作用
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:2.5
- 作者:
Tetsuya Nakamura;Antonio M. Alberola;F. Salazar;Yuichiro Saito;T. Kurashina;Joey P. Granger;R. Nagai - 通讯作者:
R. Nagai
Endothelin Type A Receptor Blockade Attenuates the Hypertension in Response to Chronic Reductions in Uterine Perfusion Pressure
内皮素 A 型受体阻断可减轻子宫灌注压慢性降低引起的高血压
- DOI:
10.1161/01.hyp.37.2.485 - 发表时间:
2001-02-01 - 期刊:
- 影响因子:0
- 作者:
Barbara T. Ale;er;er;A. Rinewalt;K. Cockrell;Matthew B. Massey;William A. Bennett;Joey P. Granger - 通讯作者:
Joey P. Granger
Tumor Necrosis Factor – (cid:1) – Induced Hypertension in Pregnant Rats Results in Decreased Renal Neuronal Nitric Oxide Synthase Expression
肿瘤坏死因子 – (cid:1) – 妊娠大鼠诱发高血压导致肾神经元一氧化氮合酶表达减少
- DOI:
10.1016/s0895-7061(01)02255-5 - 发表时间:
2002 - 期刊:
- 影响因子:0
- 作者:
Barbara T. Alexander;K. Cockrell;Matthew B. Massey;William A. Bennett;Joey P. Granger - 通讯作者:
Joey P. Granger
Joey P. Granger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joey P. Granger', 18)}}的其他基金
MCCTR/UMMC Year4 N3C Grant Initiative
MCCTR/UMMC Year4 N3C 资助计划
- 批准号:
10887860 - 财政年份:2016
- 资助金额:
$ 62.08万 - 项目类别:
Mississippi Center for Clinical and Translational Research
密西西比临床和转化研究中心
- 批准号:
10281515 - 财政年份:2016
- 资助金额:
$ 62.08万 - 项目类别:
Mississippi Center for Clinical and Translational Research
密西西比临床和转化研究中心
- 批准号:
10472628 - 财政年份:2016
- 资助金额:
$ 62.08万 - 项目类别:
International Society for the Study of Hypertension in Pregnancy (ISSHP) World Congress
国际妊娠期高血压研究学会 (ISSHP) 世界大会
- 批准号:
8838489 - 财政年份:2014
- 资助金额:
$ 62.08万 - 项目类别:
Preeclampsia, IUGR and Hypertension: Targets for Treatment
先兆子痫、IUGR 和高血压:治疗目标
- 批准号:
8385761 - 财政年份:2012
- 资助金额:
$ 62.08万 - 项目类别:
Preeclampsia, IUGR and Hypertension: Targets for Treatment
先兆子痫、IUGR 和高血压:治疗目标
- 批准号:
8518448 - 财政年份:2012
- 资助金额:
$ 62.08万 - 项目类别:
Preeclampsia, IUGR and Hypertension: Targets for Treatment
先兆子痫、IUGR 和高血压:治疗目标
- 批准号:
8385761 - 财政年份:2012
- 资助金额:
$ 62.08万 - 项目类别:
相似海外基金
Pathogenic T cells in discoid lupus erythematosus
盘状红斑狼疮中的致病性 T 细胞
- 批准号:
10664134 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Mayo Advancing Research Equity in ADRD Study in Jacksonville(MAREAS-Jax)
梅奥在杰克逊维尔推进 ADRD 研究中的研究公平性 (MAREAS-Jax)
- 批准号:
10729787 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
2/2 Collaborative Union for Cancer Research, Education, and Disparities (CURED)
2/2 癌症研究、教育和差异合作联盟 (CURED)
- 批准号:
10762045 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Defining The Role of Failed-Repair Proximal Tubule Cells in AdvancedRenal Disease in African Americans
确定修复失败的近端小管细胞在非裔美国人晚期肾病中的作用
- 批准号:
10740665 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别: